Efficacy of natalizumab in secondary progressive multiple sclerosis: analysis of two phase III trials. Dzau W, Roos I, Kalincik T. J Neurol Neurosurg Psychiatry 2025 Mar 6:jnnp-2024-335495.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dzau W, Roos I, Kalincik T. Efficacy of natalizumab in secondary progressive multiple sclerosis: analysis of two phase III trials. J Neurol Neurosurg Psychiatry 2025 Mar 6:jnnp-2024-335495.
PMID: 40050011